Correction to: Utility of the Parkinson’s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington’s disease.

Related Articles:

• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Voces Unidas Unites, Amplifies, and Showcases the Voices of a Parkinson’s Community in Phoenix January 20, 2021 Lea esta relato en español aquí. “Music is such a bright aspect of culture. It’s a way to communicate. To celebrate. To express your culture. It’s part of who we are.”    With this sentiment in mind, Dr. Claudia Martinez, MD, set out in 2007 to build a program that would not only help Hispanics living with Parkinson’s communicate and…
• Voces Unidas une, amplifica y exhibe las voces de la comunidad del Parkinson en Phoenix January 20, 2021 Traducción de Clare Blim “La música es un aspecto tan brillante de la cultura. Es una forma de comunicación. De celebración. De expresión de su cultura. Es parte de lo que somos.” Con este sentimiento en mente, Dra. Claudia Martinez, MD, empieza en 2007 a construir un programa que no solo ayuda a los hispanos que viven con el Parkinson…
• A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment. April 3, 2019 Related ArticlesA divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment. Hum Brain Mapp. 2019 Apr 01;: Authors: Aracil-Bolaños I, Sampedro F, Marín-Lahoz J, Horta-Barba A, Martínez-Horta S, Botí M, Pérez-Pérez J, Bejr-Kasem H, Pascual-Sedano B, Campolongo A, Izquierdo C, Gironell A, Gómez-Ansón B, Kulisevsky J, Pagonabarraga J Abstract Cognitive decline is a major disabling feature in Parkinson's…
• The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight. October 30, 2019 The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight. Mov Disord. 2019 Oct 29;: Authors: Bandres-Ciga S, Ahmed S, Sabir MS, Blauwendraat C, Adarmes-Gómez AD, Bernal-Bernal I, Bonilla-Toribio M, Buiza-Rueda D, Carrillo F, Carrión-Claro M, Gómez-Garre P, Jesús S, Labrador-Espinosa MA, Macias D, Méndez-Del-Barrio C, Periñán-Tocino T, Tejera-Parrado C, Vargas-González L,…
• Monthly Research Review – November 2020 November 30, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). October 26, 2016 Related ArticlesGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1-222 Authors: Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S,…
• 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
• Moments of Victory® – Jan Grimes Found the Silver Lining in Her Parkinson’s Diagnosis July 5, 2018 What has your life been like since your diagnosis? I retired in May 2017, from Louisiana State University where I was a professional collaborative pianist for 30 years and collaborated in recitals with over 650 faculty members and students. Because my identity as a pianist was so strong, I found it necessary to redefine myself and discover who I was…
• The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study. October 2, 2019 The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study. Mov Disord. 2019 Sep 30;: Authors: Chaudhuri KR, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Mamikonyan E, Martinez-Martin P Abstract BACKGROUND: The Movement Disorder Society-sponsored Nonmotor Rating Scale is an update of the existing Parkinson's disease Nonmotor Symptoms Scale modified to address some limitations in Nonmotor Symptoms Scale scoring,…
• Cognitive and behavioral assessment in Parkinson's disease. June 11, 2019 Cognitive and behavioral assessment in Parkinson's disease. Expert Rev Neurother. 2019 Jun 10;: Authors: Martinez-Horta S, Horta-Barba A, Kulisevsky J Abstract Introduction: Cognitive impairment and behavioral disturbances are common findings in Parkinson's disease (PD). Despite initially being considered late complications of the disease, it is currently accepted that almost all PD patients will exhibit cognitive and behavioral abnormalities from the…
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• European Union accused of ignoring Parkinson’s November 22, 2018 Parkinson’s campaigners from across the globe are calling on the European Union to tackle brain conditions in upcoming funding programme Campaigners from around the world are coming together to demand that Parkinson’s and other brain conditions receive funding from Horizon Europe – a seven-year EU programme led by the European Commission. The Horizon Europe programme will be taking a ‘mission-orientated’…
• Depression as a risk factor for impulse control disorders in Parkinson's disease. August 16, 2019 Depression as a risk factor for impulse control disorders in Parkinson's disease. Ann Neurol. 2019 Aug 15;: Authors: Marín-Lahoz J, Sampedro F, Martinez-Horta S, Pagonabarraga J, Kulisevsky J Abstract OBJECTIVES: To longitudinally evaluate the role of depression in the development of impulse control disorders (ICD) in Parkinson's disease (PD) patients. METHODS: Using data from the Parkinson's Progression Markers Initiative (PPMI)…
• Why should I go to a Parkinson’s disease support group? October 15, 2019 Why should I go to a Parkinson’s disease support group? Support groups play a vital role in the lives of many people with Parkinson’s disease (PD) and APDA plays a vital role in providing access to support groups around the country. In general terms, a support group is a collection of participants who meet on a regular basis, facilitated by…
• Recommendations for Screening and Rating Impulse Control Disorders in Parkinson June 26, 2019 Based on previous methods used to critique categorical rating tools, a task force commissioned by the International Parkinson’s and Movement Disorder Society released recommendations on the utility of available clinical screening instruments and rating scales used to measure impulsive and compulsive behaviors (ICBs) in Parkinson disease. This report was published in Movement Disorders. The investigators performed a systematic review of…
• Characterization of pallidocortical motor network in Parkinson disease through complex network analysis. September 11, 2019 Characterization of pallidocortical motor network in Parkinson disease through complex network analysis. J Neural Eng. 2019 Sep 10;: Authors: Xiao R, Malekmohammadi M, Pouratian N, Hu X Abstract OBJECTIVE: Deep brain stimulation (DBS) has demonstrated to be an advanced therapy for selected patients with Parkinson disease (PD) from numerous clinical trials, while its maximal therapeutic effect is capped by the…
• Is it time to back NAC? October 4, 2019   A lot of Parkinson’s research is focused on antioxidants – molecules that can reduce the level of stress a cell is under when it is not feeling well. One of the most widely discussed antioxidants on Parkinson’s online forums is a molecule called N–acetylcysteine (or NAC). Recently, the results of a small clinical trial – in which NAC was…
• Longitudinal intracortical diffusivity changes in de-novo Parkinson's disease: A promising imaging biomarker. October 18, 2019 Longitudinal intracortical diffusivity changes in de-novo Parkinson's disease: A promising imaging biomarker. Parkinsonism Relat Disord. 2019 Oct 01;68:22-25 Authors: Sampedro F, Martínez-Horta S, Marín-Lahoz J, Pagonabarraga J, Kulisevsky J Abstract Cognitive impairment and dementia in Parkinson's disease (PD) are highly disabling non-motor symptoms with no effective treatment currently available. As cortical degeneration is thought to be involved in the development…
• Shining a light on Parkinson’s November 7, 2019   NOTE: The information in today’s post should not be considered an endorsement of PhotoPharmics or the treatment they are proposing. The author of this blog has had no communication with the company. The information in this post is provided because the author has been asked by readers to discuss it. In October 2018, at the annual International Movement Disorders…
• Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia. June 19, 2019 Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia. Mov Disord. 2019 Jun 18;: Authors: Diallo A, Jacobi H, Cook A, Giunti P, Parkinson MH, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Castaldo A, Rakowicz M, Rola R, Sulek A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L,…